Anti-Rejection Drug May Boost Diabetes in Kidney Transplant Patients (HealthDay)

HealthDay - THURSDAY, May 29 (HealthDay News) -- Treatment with the anti-rejection drug sirolimus may lead to increased risk of diabetes in kidney transplant patients, say researchers who analyzed data on about 20,000 Medicare patients who had kidney transplants between 1995 and 2003.